Administration of Celecoxib for Treatment of Intracerebral Hemorrhage : A Pilot Study

• Status: Completed
• Trial end date: 2009-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Primary:

Change of volume of perihematomal edema as assessed by brain CT.

Secondary:

The change of ICH volume between the initial and the follow-up CT scans The neurological status at 90 day using E-GOS and mRS. The cumulative incidence of major and minor adverse events that occurred during and after hospitalization until the end of the study

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Celecoxib

Criteria

Inclusion Criteria:

1. Spontaneous intracerebral hemorrhage was documented by CT scanning within 24 hours of the onset of symptoms

2. Supratentorial location of hemorrhage

3. Older than 17 yrs

Exclusion Criteria:

1. Planned surgical evacuation of hematoma within 24hrs

2. Secondary ICH due to trauma or aneurismal rupture or etc

3. Taking antithrombotics or other NSAIDs previously

4. Pregnancy

5. Other physical condition, making the patient difficult to participate the study (decided by the neurologist or the physician).